Concord Medical Services (NYSE:CCM) Share Price Crosses Above Two Hundred Day Moving Average – What’s Next?

Concord Medical Services Holdings Limited (NYSE:CCM) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.22 and traded as high as $4.88. Concord Medical Services shares last traded at $4.6460, with a volume of 41,926 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Concord Medical Services in a report on Tuesday, May 26th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Concord Medical Services Price Performance

The company has a quick ratio of 0.46, a current ratio of 0.48 and a debt-to-equity ratio of 1.33. The firm has a 50 day moving average price of $4.66 and a 200 day moving average price of $4.23.

Concord Medical Services (NYSE:CCM) last announced its quarterly earnings results on Wednesday, April 29th. The company reported ($1.08) earnings per share (EPS) for the quarter.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.